Diversity of Function Is Inherent in Matricellular Proteins: an Appraisal of Thrombospondin I
暂无分享,去创建一个
[1] P. Steeg,et al. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. , 1994, Cancer research.
[2] P. Hogg. Thrombospondin 1 as an Enzyme Inhibitor , 1994, Thrombosis and Haemostasis.
[3] E. Chambaz,et al. Distinct effects of thrombospondin-1 and CISP/thrombospondin-2 on adrenocortical cell spreading , 1994, Molecular and Cellular Endocrinology.
[4] S. Schultz-Cherry,et al. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. , 1994, The Journal of biological chemistry.
[5] K. Dameron,et al. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. , 1994, Science.
[6] M. Sandler,et al. A novel protein interacts with the major transforming growth factor-beta responsive element in the plasminogen activator inhibitor type-1 gene. , 1994, The Journal of biological chemistry.
[7] S. Suchard,et al. Role of thrombospondin in mesangial cell growth: possible existence of an autocrine feedback growth circuit. , 1994, Kidney international.
[8] V. Dixit,et al. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. , 1994, The American journal of pathology.
[9] P. Bornstein,et al. Modulation of thrombospondin expression during differentiation of embryonal carcinoma cells , 1994, Journal of cellular physiology.
[10] G. Tuszynski,et al. Matrix-bound thrombospondin promotes angiogenesis in vitro , 1994, The Journal of cell biology.
[11] H. Krutzsch,et al. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin‐binding domain and synthetic peptides from the type I repeats of thrombospondin , 1993, Journal of cellular biochemistry.
[12] O. Volpert,et al. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity , 1993, The Journal of cell biology.
[13] M. Iruela-Arispe,et al. Differential expression of thrombospondin 1, 2, and 3 during murine development , 1993, Developmental dynamics : an official publication of the American Association of Anatomists.
[14] H. Erickson,et al. Gene knockouts of c-src, transforming growth factor beta 1, and tenascin suggest superfluous, nonfunctional expression of proteins , 1993, The Journal of cell biology.
[15] Josephine C. Adams,et al. The thrombospondin family , 1993, Current Biology.
[16] V. Dixit,et al. High level thrombospondin 1 expression in two NIH 3T3 cloned lines confers serum- and anchorage-independent growth. , 1993, The Journal of biological chemistry.
[17] Carol D. Laherty,et al. Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers. , 1992, The Journal of biological chemistry.
[18] Y Ikawa,et al. Mice develop normally without tenascin. , 1992, Genes & development.
[19] K. Skorstengaard,et al. Disulfides modulate RGD-inhibitable cell adhesive activity of thrombospondin , 1992, The Journal of cell biology.
[20] C. Corless,et al. Colocalization of thrombospondin and syndecan during murine development , 1992, Developmental dynamics : an official publication of the American Association of Anatomists.
[21] F. W. Wolf,et al. Characterization of mouse thrombospondin 2 sequence and expression during cell growth and development. , 1992, The Journal of biological chemistry.
[22] P. Bornstein,et al. Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin. , 1991, The Journal of biological chemistry.
[23] M. Iruela-Arispe,et al. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[24] E. Prochownik,et al. Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma. , 1991, The Journal of clinical investigation.
[25] M. L. Le Beau,et al. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[26] V. Dixit,et al. Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor. , 1987, The Journal of biological chemistry.
[27] J. Folkman. Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.
[28] P. Bornstein,et al. Thrombospondins: structure and regulation of expression , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] P. Bornstein,et al. Modulation of thrombospondin gene expression during osteoblast differentiation in MC3T3-E1 cells. , 1992, Bone.